VOYA Investment Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $14.5M | Buy |
139,289
+40,289
| +41% | +$4.21M | 0.01% | 623 |
|
2025
Q1 | $11.5M | Sell |
99,000
-3,742
| -4% | -$436K | 0.01% | 695 |
|
2024
Q4 | $8.69M | Buy |
102,742
+8,259
| +9% | +$699K | 0.01% | 784 |
|
2024
Q3 | $8.49M | Buy |
94,483
+2,679
| +3% | +$241K | 0.01% | 826 |
|
2024
Q2 | $7.39M | Buy |
91,804
+72,517
| +376% | +$5.84M | 0.01% | 851 |
|
2024
Q1 | $1.54M | Sell |
19,287
-2,354
| -11% | -$188K | ﹤0.01% | 1445 |
|
2023
Q4 | $1.72M | Sell |
21,641
-34,988
| -62% | -$2.78M | ﹤0.01% | 1429 |
|
2023
Q3 | $3.96M | Buy |
56,629
+1,172
| +2% | +$81.9K | ﹤0.01% | 1072 |
|
2023
Q2 | $3.99M | Buy |
55,457
+43,294
| +356% | +$3.11M | ﹤0.01% | 1075 |
|
2023
Q1 | $750K | Sell |
12,163
-4,199
| -26% | -$259K | ﹤0.01% | 1816 |
|
2022
Q4 | $1.26M | Buy |
16,362
+863
| +6% | +$66.6K | ﹤0.01% | 1533 |
|
2022
Q3 | $692K | Buy |
15,499
+4,642
| +43% | +$207K | ﹤0.01% | 1825 |
|
2022
Q2 | $416K | Hold |
10,857
| – | – | ﹤0.01% | 1956 |
|
2022
Q1 | $449K | Hold |
10,857
| – | – | ﹤0.01% | 1979 |
|
2021
Q4 | $410K | Sell |
10,857
-445
| -4% | -$16.8K | ﹤0.01% | 2128 |
|
2021
Q3 | $373K | Hold |
11,302
| – | – | ﹤0.01% | 2219 |
|
2021
Q2 | $762K | Sell |
11,302
-924
| -8% | -$62.3K | ﹤0.01% | 1829 |
|
2021
Q1 | $692K | Buy |
12,226
+78
| +0.6% | +$4.42K | ﹤0.01% | 1831 |
|
2020
Q4 | $990K | Buy |
12,148
+2,542
| +26% | +$207K | ﹤0.01% | 1520 |
|
2020
Q3 | $684K | Hold |
9,606
| – | – | ﹤0.01% | 1488 |
|
2020
Q2 | $790K | Sell |
9,606
-3,745
| -28% | -$308K | ﹤0.01% | 1388 |
|
2020
Q1 | $785K | Buy |
13,351
+961
| +8% | +$56.5K | ﹤0.01% | 1348 |
|
2019
Q4 | $1.28M | Buy |
+12,390
| New | +$1.28M | ﹤0.01% | 1317 |
|
2019
Q3 | – | Sell |
-9,725
| Closed | -$250K | – | 2552 |
|
2019
Q2 | $250K | Buy |
+9,725
| New | +$250K | ﹤0.01% | 2173 |
|